BackSienna Biopharmaceuticals Overview

Sienna Biopharmaceuticals EBIT

EBIT (Earnings Before Interest and Taxes) analysis for SNNAQ.

Quarterly EBIT

-$6.04M
↑ 63.6% YoY

As of Sep 30, 2019

Annual EBIT (TTM)

-$49.41M
↑ 30.17% YoY

Trailing 12 months ending Sep 30, 2019

Average EBIT (Comparison Companies)

EBIT History

EBIT Comparison

Annual EBIT Growth Rate (%)

Annual EBIT Growth (Absolute)

Jump to metric
Total RevenueCost of RevenueGross ProfitResearch & DevelopmentSelling, General & AdminOperating IncomeOther Income Expense NetEBITIncome TaxNet IncomeProfit Margin